Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Management of Mitral Valve Disease in the Elderly.

The International journal of angiology : official publication of the International College of Angiology, Inc·2025
Same author

Myocardial Infarction with Nonobstructive Coronary Artery Disease-Definition, Etiopathogenesis, Diagnosis, and Management.

The International journal of angiology : official publication of the International College of Angiology, Inc·2024
Same author

Diastolic Heart Failure Mechanisms and Assessment Revisited.

Journal of clinical medicine·2024
Same author

Contemporary Management of the Failing Fontan.

Journal of clinical medicine·2024
Same author

A case report of recurrent primary posterior mediastinal perivascular epithelioid cell tumour compressing the right inferior pulmonary vein, atria, and inferior vena cava.

European heart journal. Case reports·2024
Same author

Potential Expanded Applications of Minimally Invasive Cardiac Myectomy.

Journal of the American College of Cardiology·2023

Related Experiment Video

Updated: May 21, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Asymptomatic aortic stenosis: management revisited.

Ramdas G Pai1, Ajit D Pai

  • 1Department of Cardiology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA. ramdaspai@yahoo.com

Indian Heart Journal
|June 28, 2012
PubMed
Summary
This summary is machine-generated.

Severe aortic stenosis (AS) often lacks symptoms, yet guidelines restrict aortic valve replacement (AVR). This review suggests considering AVR for asymptomatic severe AS, especially in high-risk patients.

More Related Videos

A Minimally Invasive Model of Aortic Stenosis in Swine
06:51

A Minimally Invasive Model of Aortic Stenosis in Swine

Published on: October 20, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

A Minimally Invasive Model of Aortic Stenosis in Swine
06:51

A Minimally Invasive Model of Aortic Stenosis in Swine

Published on: October 20, 2023

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Valvular Heart Disease

Background:

  • Aortic stenosis (AS) is a prevalent condition, frequently necessitating valve surgery in Western countries.
  • Degenerative calcification is the primary cause of AS, with incidence increasing in aging populations.
  • Current guidelines restrict aortic valve replacement (AVR) to symptomatic patients or those with left ventricular (LV) dysfunction, unless concurrent cardiac surgery is planned.

Purpose of the Study:

  • To critically evaluate the evidence underpinning current guidelines for severe AS management.
  • To assess the reliability of symptoms in decision-making for AVR.
  • To analyze contemporary data on the natural history of asymptomatic severe AS and inform treatment recommendations.

Main Methods:

  • Review of natural history studies of AS.
  • Analysis of risk and durability data for AVR.
  • Examination of contemporary data on asymptomatic severe AS progression and outcomes.

Main Results:

  • Current guidelines for AVR in severe AS are based on older natural history data and may not reflect modern surgical risks and outcomes.
  • Symptom assessment can be unreliable for determining the optimal timing of AVR in severe AS.
  • Emerging data suggest potential benefits of AVR in select asymptomatic severe AS patients, particularly those with high-risk profiles.

Conclusions:

  • The Class III recommendation against AVR in asymptomatic severe AS should be reconsidered.
  • Surgical intervention should be considered for a broader range of severe AS patients, including asymptomatic individuals with high-risk profiles.
  • Further randomized trials are needed to definitively guide therapy for asymptomatic severe AS.